Markers of Endothelial Dysfunction in Kawasaki Disease: An Update

被引:1
|
作者
Kumrah, Rajni [1 ]
Goyal, Taru [1 ]
Rawat, Amit [1 ]
Singh, Surjit [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Pediat, Allergy Immunol Unit, Chandigarh, India
关键词
Circulating endothelial cells; Endothelial progenitor cells; Oxidative stress; Reactive oxygen species; Endothelial dysfunction; CORONARY-ARTERY LESIONS; NITRIC-OXIDE PRODUCTION; LONG-TERM MANAGEMENT; GROWTH-FACTOR; PROGENITOR CELLS; OXIDATIVE STRESS; EPIDEMIOLOGIC FEATURES; CARDIOVASCULAR-DISEASE; HEALTH-PROFESSIONALS; ADIPONECTIN LEVELS;
D O I
10.1007/s12016-024-08985-5
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Kawasaki disease (KD) is a medium vessel vasculitis that has a special predilection for coronary arteries. Cardiovascular complications include the development of coronary artery abnormalities (CAAs) and myocarditis. Endothelial dysfunction (ED) is now recognized to be a key component in the pathogenesis of KD and is believed to contribute to the development of CAAs. ED has been evaluated by several clinical parameters. However, there is paucity of literature on laboratory markers for ED in KD. The evaluation of ED can be aided by the identification of biomarkers such as oxidative stress markers, circulating cells and their progenitors, angiogenesis factors, cytokines, chemokines, cell-adhesion molecules, and adipokines. If validated in multicentric studies, these biomarkers may be useful for monitoring the disease course of KD. They may also provide a useful predictive marker for the development of premature atherosclerosis that is often a concern during long-term follow-up of KD. This review provides insights into the current understanding of the significance of ED in KD.
引用
收藏
页码:99 / 111
页数:13
相关论文
共 50 条
  • [31] Update on the Management of Kawasaki Disease
    Friedman, Kevin G.
    Jone, Pei-Ni
    PEDIATRIC CLINICS OF NORTH AMERICA, 2020, 67 (05) : 811 - 819
  • [32] KAWASAKI DISEASE - CANADIAN UPDATE
    ROWE, RD
    ROSE, V
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1985, 132 (01) : 25 - 28
  • [33] An Update on Treatment of Kawasaki Disease
    Pilania, Rakesh Kumar
    Jindal, Ankur Kumar
    Guleria, Sandesh
    Singh, Surjit
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2019, 5 (01) : 36 - 55
  • [34] Markers of endothelial dysfunction
    Müller, MM
    Griesmacher, A
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (02) : 77 - 85
  • [35] Endothelial Dysfunction in Children within 5 Years after Onset of Kawasaki Disease
    Ishikawa, Takamichi
    Iwashima, Satoru
    JOURNAL OF PEDIATRICS, 2013, 163 (04): : 1117 - 1121
  • [36] Coronary endothelial dysfunction after Kawasaki disease:: Evaluation by intracoronary injection of acetylcholine
    Yamakawa, R
    Ishii, M
    Sugimura, T
    Akagi, T
    Eto, G
    Iemura, M
    Tsutsumi, T
    Kato, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (05) : 1074 - 1080
  • [37] Vascular endothelial dysfunction and oxidative stress in adult patients with the history of Kawasaki disease
    Hamaoka, Kenji
    Niboshi, Ayumi
    Ozawa, Sei-Ichiro
    Yahata, Tomoyo
    Fujii, Maiko
    Hamaoka, Akiko
    Sakata, Koichi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 : 98 - 98
  • [38] Endothelial microparticles as markers of endothelial dysfunction
    Horstman, LL
    Jy, W
    Jimenez, JJ
    Ahn, YS
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 1118 - 1135
  • [39] THE ENDOTHELIAL GLYCOCALYX IS DAMAGED WITH WORSENING KIDNEY DISEASE AND CORRELATES WITH MARKERS OF ENDOTHELIAL DYSFUNCTION
    Liew, Hui
    McMahon, Lawrence
    Roberts, Matthew
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [40] The Relationship between Endothelial Dysfunction and Endothelial Cell Markers in Peripheral Arterial Disease
    Igari, Kimihiro
    Kudo, Toshifumi
    Toyofuku, Takahiro
    Inoue, Yoshinori
    PLOS ONE, 2016, 11 (11):